Sullivan, Bruyette, Speros & Blaney’s Boston Scientific BSX Stock Holding History

Sullivan, Bruyette, Speros & Blaney’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$109K	Hold	2,831	–	–	﹤0.01%	402
2020 Q4	$102K	Hold	2,831	–	–	﹤0.01%	394
2020 Q3	$108K	Buy	+2,831	New	+$109K	0.01%	336
2020 Q1	–	Sell	-2,831	Closed	-$128K	–	304
2019 Q4	$128K	Hold	2,831	–	–	0.01%	307
2019 Q3	$115K	Buy	+2,831	New	+$120K	0.01%	310

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Sullivan, Bruyette, Speros & Blaney's BSX Position: Q1 2021 in Review

Sullivan, Bruyette, Speros & Blaney held its Boston Scientific (BSX) position steady in Q1 2021 at 2,831 shares worth $109K. The position accounts for ﹤0.01% of the portfolio, ranked #402.

Sullivan, Bruyette, Speros & Blaney first reported a position in BSX in Q3 2019 and has held it in 5 quarters since. The position peaked at $128K in Q4 2019. 831 funds tracked by Wall St. Rank hold BSX as of Q1 2021.

Sullivan, Bruyette, Speros & Blaney held 2,831 shares of Boston Scientific worth $109K as of Q1 2021.
Sullivan, Bruyette, Speros & Blaney left its Boston Scientific share count unchanged in Q1 2021.
Boston Scientific made up ﹤0.01% of Sullivan, Bruyette, Speros & Blaney's portfolio in Q1 2021, its #402 holding.
Sullivan, Bruyette, Speros & Blaney first reported a position in Boston Scientific in Q3 2019 and has held it in 5 quarters since.
Sullivan, Bruyette, Speros & Blaney's Boston Scientific position peaked at $128K in Q4 2019.
831 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2021.

Based on Sullivan, Bruyette, Speros & Blaney's 13F filing for Q1 2021, filed 10 May 2021.